Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4322)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 15, 2025 (publication date) through Feb 10, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Wang Q, Li QR, Xu L, Yuan ZC, Liu X, Tang MJ, Luo M, Zhong XW, Ma Q, Guo XL. BIBR1532 inhibits proliferation and metastasis of esophageal squamous cancer cells by inducing telomere dysregulation. World J Gastrointest Oncol 2025; 17(1): 99376 [PMID: 39817136 DOI: 10.4251/wjgo.v17.i1.99376] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Wang Q, Li QR, Xu L, Yuan ZC, Liu X, Tang MJ, Luo M, Zhong XW, Ma Q, Guo XL. BIBR1532 inhibits proliferation and metastasis of esophageal squamous cancer cells by inducing telomere dysregulation. World J Gastrointest Oncol 2025; 17(1): 99376 [PMID: 39817136 DOI: 10.4251/wjgo.v17.i1.99376] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i1/99376.htm |
| Number | Citing Articles |
| 1 |
Man Luo, Jiang Zhu, Yong Yang, Chongbo Liao, Xiao Liu, Maoju Tang, Lei Xu, Xiaowu Zhong, Qiang Ma, Xiaolan Guo. Fedratinib reveals chemotherapeutic potential in esophageal squamous cell cancer. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1689663
|
| 2 |
Yun Zhang, Mengxiang Quan, Qinlan Chen, Hongdi Han, Xianling Zhang, Xiangwei Xu, Zunyuan Wang. Recent progress of METTL3 inhibitors for cancer therapeutics: design, optimization and potential applications. RSC Medicinal Chemistry 2026; doi: 10.1039/D5MD00867K
|
| 3 |
Xue-Juan Zhang, Nai-Xuan Deng, Huan-Qing Zhang, Jie-Zuan Cen, Zi-Xuan Zheng, Meng-Qin Guo, Zheng-Wei Huang. Solid dispersion of BIBR1532: A potent therapeutic for oesophageal squamous cancer. World Journal of Gastrointestinal Oncology 2026; 18(1): 114924 doi: 10.4251/wjgo.v18.i1.114924
|